ORBIMED ADVISORS LLC sold 3.4% of their position (235.57K shares) of PASSAGE BIO, INC. on the open market
Open‑market sale worth $78.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/24/2025ACC: 0000947871-25-000423
-235.57K
Net shares
Net seller
$78.7K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
235.57K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−78.05K
Price / share
$0.34
Trade value
$26.54K
% of position
1.1%
4/22/2025
6.89M→6.81M
Common Stock
Indirect
Shares
−89.33K
Price / share
$0.34
Trade value
$30.37K
% of position
1.3%
4/23/2025
6.81M→6.72M
Common Stock
Indirect
Shares
−68.19K
Price / share
$0.32
Trade value
$21.82K
% of position
1.0%
4/24/2025
6.72M→6.65M
Total
Net shares
−235.57K
Net value
-$78.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/22/2025 | S · Sale | −78.05K | $0.34 | $26.54K | 1.1% | 6.89M | 6.81M |
| Common Stock Indirect | 4/23/2025 | S · Sale | −89.33K | $0.34 | $30.37K | 1.3% | 6.81M | 6.72M |
| Common Stock Indirect | 4/24/2025 | S · Sale | −68.19K | $0.32 | $21.82K | 1.0% | 6.72M | 6.65M |
| Total | −235.57K | -$78.73K | ||||||
Derivative Transactions0
No derivative transactions reported